| Literature DB >> 20858287 |
Yinnan Mu1, Feng Ding, Peng Cui, Jingqun Ao, Songnian Hu, Xinhua Chen.
Abstract
BACKGROUND: The large yellow croaker (Pseudosciaena crocea) is an economically important marine fish in China suffering from severe outbreaks of infectious disease caused by marine bacteria such as Aeromonas hydrophila (A. hydrophila), resulting in great economic losses. However, the mechanisms involved in the immune response of this fish to bacterial infection are not fully understood. To understand the molecular mechanisms underlying the immune response to such pathogenic bacteria, we used high-throughput deep sequencing technology to investigate the transcriptome and comparative expression profiles of the large yellow croaker infected with A. hydrophila.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20858287 PMCID: PMC2997002 DOI: 10.1186/1471-2164-11-506
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Length statistics of scaffolds obtained from the large yellow croaker transcriptome library. The length distributions of the transcriptome library. Sequences with lengths of 500-1000 bp were most abundant, making up 47% of the scaffolds.
GO function annotation results of 8216 unigenes
| Term | GO ID | Description | %* | P Value | |
|---|---|---|---|---|---|
| CC_2 | GO:0044464 | cell part | 2650 | 98.84 | 0.000013 |
| CC_2 | GO:0005622 | intracellular | 2041 | 76.13 | 0.000000 |
| CC_2 | GO:0044424 | intracellular part | 1707 | 63.67 | 0.000000 |
| CC_2 | GO:0043229 | intracellular organelle | 1351 | 50.39 | 0.000000 |
| CC_2 | GO:0043227 | membrane-bounded organelle | 1103 | 41.14 | 0.000000 |
| CC_2 | GO:0044446 | intracellular organelle part | 466 | 17.38 | 0.000000 |
| CC_2 | GO:0044422 | organelle part | 466 | 17.38 | 0.000000 |
| CC_2 | GO:0043234 | protein complex | 410 | 15.29 | 0.000000 |
| CC_2 | GO:0043228 | non-membrane-bounded organelle | 366 | 13.65 | 0.000000 |
| CC_2 | GO:0030529 | ribonucleoprotein complex | 210 | 7.83 | 0.000000 |
| CC_2 | GO:0031090 | organelle membrane | 137 | 5.11 | 0.001153 |
| CC_2 | GO:0043233 | organelle lumen | 135 | 5.04 | 0.000000 |
| CC_2 | GO:0031967 | organelle envelope | 98 | 3.66 | 0.000398 |
| CC_2 | GO:0012505 | endomembrane system | 86 | 3.21 | 0.021749 |
| MF_2 | GO:0000166 | nucleotide binding | 827 | 22.39 | 0.000000 |
| MF_2 | GO:0016787 | hydrolase activity | 674 | 18.25 | 0.000000 |
| MF_2 | GO:0016740 | transferase activity | 606 | 16.4 | 0.000001 |
| MF_2 | GO:0001882 | nucleoside binding | 506 | 13.7 | 0.000000 |
| MF_2 | GO:0016874 | ligase activity | 122 | 3.3 | 0.000001 |
| MF_2 | GO:0003735 | structural constituent of ribosome | 118 | 3.19 | 0.000000 |
| MF_2 | GO:0048037 | cofactor binding | 96 | 2.6 | 0.001411 |
| MF_2 | GO:0060589 | nucleoside-triphosphatase regulator activity | 77 | 2.08 | 0.001763 |
| MF_2 | GO:0008135 | translation factor activity, nucleic acid binding | 60 | 1.62 | 0.000000 |
| MF_2 | GO:0016853 | isomerase activity | 58 | 1.57 | 0.000002 |
| MF_2 | GO:0003702 | RNA polymerase II transcription factor activity | 32 | 0.87 | 0.000002 |
| MF_2 | GO:0051540 | metal cluster binding | 24 | 0.65 | 0.026354 |
| MF_2 | GO:0008430 | selenium binding | 16 | 0.43 | 0.031351 |
| MF_2 | GO:0019825 | oxygen binding | 11 | 0.3 | 0.022460 |
| MF_2 | GO:0004601 | peroxidase activity | 9 | 0.24 | 0.072047 |
| MF_2 | GO:0008641 | small protein activating enzyme activity | 5 | 0.14 | 0.071494 |
| BP_2 | GO:0044238 | primary metabolic process | 1571 | 50.18 | 0.000000 |
| BP_2 | GO:0044237 | cellular metabolic process | 1466 | 46.82 | 0.000000 |
| BP_2 | GO:0043170 | macromolecule metabolic process | 1271 | 40.59 | 0.000000 |
| BP_2 | GO:0009058 | biosynthetic process | 637 | 20.34 | 0.000000 |
| BP_2 | GO:0006807 | nitrogen compound metabolic process | 608 | 19.42 | 0.000020 |
| BP_2 | GO:0051234 | establishment of localization | 533 | 17.02 | 0.051495 |
| BP_2 | GO:0006810 | transport | 528 | 16.86 | 0.055745 |
| BP_2 | GO:0009056 | catabolic process | 235 | 7.51 | 0.000000 |
| BP_2 | GO:0033036 | macromolecule localization | 214 | 6.83 | 0.000000 |
| BP_2 | GO:0045184 | establishment of protein localization | 178 | 5.69 | 0.000000 |
| BP_2 | GO:0006996 | organelle organization | 154 | 4.92 | 0.031676 |
| BP_2 | GO:0051641 | cellular localization | 139 | 4.44 | 0.000000 |
| BP_2 | GO:0051649 | establishment of localization in cell | 132 | 4.22 | 0.000000 |
| BP_2 | GO:0065008 | regulation of biological quality | 124 | 3.96 | 0.055589 |
| BP_2 | GO:0022607 | cellular component assembly | 107 | 3.42 | 0.001415 |
| BP_2 | GO:0042221 | response to chemical stimulus | 88 | 2.81 | 0.067111 |
| BP_2 | GO:0043933 | macromolecular complex subunit organization | 84 | 2.68 | 0.000005 |
| BP_2 | GO:0016192 | vesicle-mediated transport | 75 | 2.4 | 0.000639 |
| BP_2 | GO:0006066 | alcohol metabolic process | 64 | 2.04 | 0.022528 |
| BP_2 | GO:0019725 | cellular homeostasis | 63 | 2.01 | 0.000479 |
| BP_2 | GO:0070271 | protein complex biogenesis | 58 | 1.85 | 0.000005 |
| BP_2 | GO:0034621 | cellular macromolecular complex subunit organization | 58 | 1.85 | 0.003498 |
| BP_2 | GO:0002520 | immune system development | 54 | 1.72 | 0.000019 |
| BP_2 | GO:0051301 | cell division | 45 | 1.44 | 0.019598 |
| BP_2 | GO:0022613 | ribonucleoprotein complex biogenesis | 38 | 1.21 | 0.000011 |
| BP_2 | GO:0019637 | organophosphate metabolic process | 38 | 1.21 | 0.029496 |
| BP_2 | GO:0009893 | positive regulation of metabolic process | 37 | 1.18 | 0.060638 |
| BP_2 | GO:0006413 | translational initiation | 25 | 0.8 | 0.000041 |
| BP_2 | GO:0051236 | establishment of RNA localization | 15 | 0.48 | 0.017466 |
| BP_2 | GO:0042440 | pigment metabolic process | 14 | 0.45 | 0.004606 |
| BP_2 | GO:0044087 | regulation of cellular component biogenesis | 13 | 0.42 | 0.008675 |
*, indicates the percentage of genes in the specific subcategory from each of the three GO ontologies.
Statistically significant KEGG classifications of large yellow croaker genes
| Category | %* | P value | |
|---|---|---|---|
| Huntington's disease | 81 | 2.62 | 0.000000 |
| Ribosome | 70 | 2.26 | 0.000000 |
| Pathways in cancer | 70 | 2.26 | 0.000020 |
| Oxidative phosphorylation | 69 | 2.23 | 0.000000 |
| Alzheimer's disease | 67 | 2.17 | 0.000000 |
| Parkinson's disease | 62 | 2 | 0.000000 |
| Ubiquitin mediated proteolysis | 54 | 1.75 | 0.000000 |
| Lysosome | 54 | 1.75 | 0.000000 |
| Purine metabolism | 51 | 1.65 | 0.000192 |
| MAPK signaling pathway | 47 | 1.52 | 0.027690 |
| Regulation of actin cytoskeleton | 47 | 1.52 | 0.000330 |
| Focal adhesion | 43 | 1.39 | 0.000870 |
| Pyrimidine metabolism | 37 | 1.2 | 0.000079 |
| Insulin signaling pathway | 35 | 1.13 | 0.000092 |
| Neurotrophin signaling pathway | 35 | 1.13 | 0.000014 |
| Chemokine signaling pathway | 34 | 1.1 | 0.041450 |
| Proteasome | 32 | 1.03 | 0.000000 |
| T cell receptor signaling pathway | 29 | 0.94 | 0.000161 |
| Leukocyte transendothelial migration | 29 | 0.94 | 0.000788 |
| B cell receptor signaling pathway | 27 | 0.87 | 0.000001 |
*, indicates the percentage of genes in each pathway from 3094 genes mapped to KEGG.
Representative genes significantly differentially expressed after A. hydrophila infection
| Gene Name | Describe | Fold | P value | |
|---|---|---|---|---|
| TLR1 | P79800 | Toll-like receptor 1 | 18/0 | 0.000001 |
| TLR2 | NM_212812 | Toll-like receptor 2 | 0/94 | 0 |
| TLR3 | BAD01045 | Toll-like receptor 3 | 4/0 | 0 |
| TLR22 | NM_001128675 | Toll-like receptor 22 | -2.5 | 0 |
| IL-1β | gb|AAP33156.1| | Interleukin-1β | +17.9 | 0 |
| IL-8 | XP_695462 | Interleukin-8 | +20.8 | 0.000007 |
| IL-2rgb | NM_001123050 | Interleukin 2 receptor, gamma b | +2.3 | 0.001956 |
| IL-4r | NM_001013282 | Interleukin 4 receptor | +1.4 | 0.000015 |
| IL-6r | NM_001114318 | Interleukin 6 receptor | +2.2 | 0.000023 |
| CCL-4 | CAO78735.1 | CC chemokine ligand 4 | +2.75 | 0 |
| CCL-c25v | NM_001115103 | Chemokine CCL-C25v | 0/34 | 0 |
| CCr-1 | ref|NP_001028030.1 | CC chemokine receptor type 1 | +9.6 | 0 |
| CCr-12.3 | NM_001045027 | CC chemokine receptor family-like | +4.4 | 0 |
| Crlf-3 | ref|NP_001167401.1 | cytokine receptor-like factor 3 | 65/0 | 0 |
| TNFaip8 | NM_200332 | TNF, alpha-induced protein 8-like protein 1 | -2.2 | 0.043671 |
| TNFsf10l2 | NM_001002593 | TNF superfamily, member 10 like 2 | -1.3 | 0.00616 |
| Jfmip1a | dbj|BAC10650.1| | MIP1alpha | -2.5 | 0.000505 |
| Cklr | gb|AAP58737.1| | C-type lectin receptor | +1.7 | 0 |
| Blnk | NM_212838 | B-cell linker | -1.6 | 0 |
| zgc:55347 | NM_213522 | Immunoglobulin binding protein 1 | 4/0 | 0.026366 |
| Fcgr1 | gb|ACN10126.1| | High affinity immunoglobulin gammaFc receptor I precursor | +2.6 | 0.049003 |
| CD3g/d | ref|NP_001033072.1 | CD3 gamma/delta | -1.9 | 0 |
| Rad23b | NM_200564 | RAD23 homolog B | +2.4 | 0.018151 |
| Fas | ref|NP_001075464. | Fas | 4/0 | 0.026366 |
| Casp9 | NM_001007404 | caspase9 apoptosis-related cysteine protease | +5.8 | 0.000013 |
| Was | emb|CAQ15295.1| | Wiskott-Aldrich syndrome | -3.3 | 0.017699 |
| Tpsn | NM_130974 | Tapasin | +2.3 | 0 |
| Lipf | NM_213404 | Lipf protein | +2.4 | 0 |
| Hsp90a.1 | NM_131328 | Heat shock protein HSP 90-alpha 1 | +1.2 | 0.048885 |
| Gadd45al | NM_200576 | Growth arrest and DNA-damage-inducible, beta | +1.7 | 0 |
| Prdx1 | NM_001013471 | Peroxiredoxin 1 | +5.8 | 0 |
| Prdx2 | NM_001002468 | Peroxiredoxin 2 | -1.5 | 0 |
| Glrx5 | NM_213021 | Glutaredoxin 5 | +1.3 | 0.015063 |
| Gpx1b | NM_001004634 | Glutathione peroxidase 1b | +1.4 | 0 |
| Gpx4b | NM_001030070 | Glutathione peroxidase 4b | -1.4 | 0 |
| zgc:85657 | NM_214749 | Non-homologous end-joining factor 1 | -1.4 | 0.02618 |
| Mpx | NM_212779 | Myeloid-specific peroxidase | -1.9 | 0.02238 |
| Ube2nl | NM_200342 | Ubiquitin-conjugating enzyme E2N-like | +2 | 0 |
| NF-kB2 | NM_001001840 | NF-kB, p49/p100 | -1.7 | 0 |
| NF-kBie | NM_001080089 | NF-kB 2 inhibitor, epsilon | +1.7 | 0 |
| Jak1 | NM_131073 | Janus kinase 1 | +6.1 | 0.003023 |
| Stat1 | ref|NP_001117126.1| | STAT1 alpha | +3.9 | 0.027891 |
| Jun | NM_199987 | c-Jun | 0/5 | 0.02144 |
| Jund | NM_001128342 | Jun D proto-oncogene | +1.5 | 0.012807 |
| Xbp1 | NM_131874 | X-box binding protein 1 | 0/6 | 0.011301 |
| Smad9 | NM_001004014 | Smad9 | -3.6 | 0.031597 |
| Slp-1 | gb|AAC41262.1| | Transcription factor | 0/4 | 0.040678 |
| Srf | gb|AAH50480.1| | Srf protein | -1.5 | 0.006007 |
| Tp53 | NM_131327 | Cellular tumor antigen p53 | -1.2 | 0.031928 |
| Cebpa | NM_131885 | CCAAT/enhancer binding protein alpha | 11/0 | 0.00014 |
| Pdlim1 | NM_001017870 | PDZ and LIM domain 1 | +2.1 | 0.000003 |
| Ahr2b | ref|NP_001033052.1| | Aryl hydrocarbon receptor 2B | +2.3 | 0.00573 |
| IRF | dbj|BAA83468.1| | interferon regulatory factor | +2.9 | 0 |
| IRF4 | NM_001122710 | interferon regulatory factor 4 | +1.2 | 0.040115 |
| IRF9 | NM_205710 | interferon regulatory factor 9 | +2.3 | 0 |
| Max | NM_131220 | Myc-associated factor X | +1.3 | 0.003228 |
| Rargb | NM_001083310 | Retinoic acid receptor gamma | 13/0 | 0.000031 |
| Ldb1a | NM_131313 | LIM domain-binding protein 4 | +1.6 | 0.0016 |
| Cse1l | NM_201450 | Chromosome segregation 1-like | -1.2 | 0.045136 |
| Ppp1r10 | NM_212568 | protein phosphatase 1, regulatory subunit 10 | -1.2 | 0.00723 |
| Ppp1caa | NM_214811 | protein phosphatase 1, catalytic subunit alpha | -3.9 | 0.007564 |
| Gtf2h2 | NM_201581 | General transcription factor IIH, polypeptide 2 | 4/0 | 0.026366 |
| Gtf2h3 | NM_001002564 | General transcription factor IIH, polypeptide 3 | +2.5 | 0.000295 |
| Gf2f2 | NM_001017832 | General transcription factor IIF, polypeptide 2 | +1.4 | 0.021645 |
| Gtf2e2 | NM_212731 | General transcription factor IIE, polypeptide 2, beta | +31.9 | 0 |
Limitations of all differentially expressed genes are based on P < 0.05. A P value < 0.05 indicated that the gene was significantly altered after bacterial challenge. The absolute value of "Fold" means the magnitude of up- or downregulation for each gene/homolog after bacterial challenge; "+" indicates upregulation, "-" indicates downregulation, and "0" indicates the gene was not found in one library. "Accession NO" is GenBank identifiers for the conformable reference sequences.
Figure 2Gene list involved in TLR pathway generated by KEGG. Red indicates significantly increased expression; pink, not remarkably increased expression; blue, significantly decreased expression; cyan, not remarkably decreased expression; and gray, unchanged expression. White denotes genes that were not identified in the expression profile analysis.
Figure 3The MAPK signaling pathways generated by GenMAPP. The map-based pathway was made using the GenMAPP software package. A total of 4004 Mus musculus homologs were used to create the GenMAPP. Mus musculus homologs were identified by searching the 8216 unigenes against the zebrafish RefSeq data downloaded from the UCSC website and then the database of HomoloGene at the NCBI. Red indicates significantly increased expression; pink, not remarkably increased expression; blue, significantly decreased expression; cyan, not remarkably decreased expression; and gray, unchanged expression. White denotes genes that were not identified in the expression profile analysis.
Figure 4The TCR signaling pathways generated by GenMAPP. The map-based pathway was made using the GenMAPP software package. A total of 4004 Mus musculus homologs were used to create the GenMAPP. Mus musculus homologs were identified by searching the 8216 unigenes against the zebrafish RefSeq data downloaded from the UCSC website and then the database of HomoloGene at the NCBI. Red indicates significantly increased expression; pink, not remarkably increased expression; blue, significantly decreased expression; cyan, not remarkably decreased expression; and gray, unchanged expression. White denotes genes that were not identified in the expression profile analysis.
Figure 5The expression analysis of selected genes from the expression profile by relative quantitative real-time PCR. Total RNA was extracted from spleens of fish infected with A. hydrophila or injected with 0.9% NaCl. Real-time PCR was used to validate gene expression changes in the TLR pathway (A), cytokines (B), the MAPK signaling pathway (C), and the TCR signaling pathway (D). Increases and decreases in relative levels of transcripts with respect to the control β-actin gene are shown. For each gene, the black bar indicates the gene expression ratio of fish injected with 0.9% NaCl and is defined as 1; the grey bar indicates the expression ratio of fish infected with A. hydrophila, with associated standard error bars. Statistical significance of the relative expression ratio is indicated (*, P < 0.01).